Brind.
  1. Moderna and Merck are developing cancer vaccines in partnership, while Moderna is also seeking approval for its seasonal influenza vaccine.

Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.

14 reports, 6 independent Updated Oct 14
Gone quiet Reached 3 outlets in its first 24 hours
Reports
14
Developments
6
Repetition
71%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 6 independent outlets

Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.

Who's involved

What this event is mainly about
FDAModernaMerck

How it developed

Newest first. Tap a step to see who reported it.
  1. Merck and Moderna funded an Australian-led clinical trial involving the University of Sydney.Sub-event
  2. Moderna completed a successful Phase III mRNA vaccine trial with MSD and Geneva University Hospitals.1 source
  3. Moderna and Merck announced initial results from a late-stage trial for their novel cancer treatment.Sub-event
  4. Merck faces FDA decision deadlines for its cancer vaccine partnership with Moderna.1 source
  5. Collaboration between Moderna and Merck KGaA reaches PDUFA decision deadlines.1 source
  6. Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.1 source

Keep exploring

Part of

Moderna and Merck are developing cancer vaccines in partnership, while Moderna is also seeking approval for its seasonal influenza vaccine. All 2 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped
6 more outlets ran the same wire story